Table 1:

Time required for incremental steps in clinical trial initiation across participating sites

Type of site; parameterOverall; time, dResearch ethics board; time, dLegal; time, d
Protocol sent to site activationProtocol sent to first patient enrolledSite activation to first patient enrolledProtocol sent to REB submissionREB submission to approvalREB approval to site activationProtocol sent to contract submissionContract submission to full contract executionFull contract execution to site activation
All hospitals
Mean ± SD128.0 ± 99.6151.3 ± 93.348.8 ± 54.544.8 ± 44.113.4 ± 29.465.1 ± 57.650.7 ± 49.743.3 ± 40.031.4 ± 45.1
Median (IQR)111 (38.8–189.3)169 (53–232)32 (4–76)41 (10–56)4.5 (1–12)35 (22–103.5)42 (20.5–50.8)24.5 (15–57.8)10 (5.5–26.5)
Range15–41214–3581–2104–1950–1690–2394–2375–1640–216
Academic hospitals,n = 26
Mean ± SD102.7 ± 94.4109.7 ± 96.533.9 ± 47.824.5 ± 24.219.4 ± 39.052.4 ± 50.130.6 ± 22.438.7 ± 42.815.9 ± 21.0
Median (IQR)68.5 (25.3–182.3)71 (27.5–218.8)5 (2.3–58.5)16 (5–38)5 (1–16)32.5 (13.3–93.5)41 (4–43)22 (15–40)8 (4–21)
Range15–39214–2661–1404–840–1690–1604–825–1640–73
Missing044660991
Community hospitals,n = 22
Mean ± SD158.3 ± 101.5199.4 ± 66.365.9 ± 59.470.1 ± 51.95.8 ± 6.280.8 ± 64.173.5 ± 63.548.5 ± 38.949.0 ± 58.6
Median (IQR)118.5 (91.3–192)206 (169–235)45 (24–103.5)51.5 (43–76.3)4 (1.8–8.3)60 (30–133)50 (42–84)49 (21–59.5)19.5 (8–87.5)
Range28–41239–3581–21011–1950–2310–2395–2377–1570–216
Missing033661770
Regional ethics submission sites,n = 4
Mean ± SD7 ± 4.9
Median (IQR)7 (4–10)
Range1–13
Missing1
  • Note: REB = research ethics board.